ambulatory heart monitor

Hillrom's retreat from $375M Bardy Diagnostics acquisition countered in court
By Dave Muoio | 04:23 pm | March 03, 2021
Hillrom says that lower-than-expected reimbursement rates proposed in late January void the deal. But the cardiac-monitoring device maker asserts they were accounted for during negotiations.